Global Bio-chem Technology Group Company Limited
Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, rest of Asia, the Americas, and internationally. It operates through four segments: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company offers corn refined products, inclu… Read more
Global Bio-chem Technology Group Company Limited (GBCMY) - Total Assets
Latest total assets as of June 2025: $4.69 Billion USD
Based on the latest financial reports, Global Bio-chem Technology Group Company Limited (GBCMY) holds total assets worth $4.69 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Global Bio-chem Technology Group Company Limited - Total Assets Trend (2000–2024)
This chart illustrates how Global Bio-chem Technology Group Company Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Global Bio-chem Technology Group Company Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Global Bio-chem Technology Group Company Limited's total assets of $4.69 Billion consist of 46.2% current assets and 53.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.9% |
| Accounts Receivable | $1.72 Billion | 37.9% |
| Inventory | $205.51 Million | 4.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.05 Million | 0.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Global Bio-chem Technology Group Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Global Bio-chem Technology Group Company Limited's current assets represent 46.2% of total assets in 2024, an increase from 41.8% in 2000.
- Cash Position: Cash and equivalents constituted 1.9% of total assets in 2024, down from 8.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 37.9% of total assets.
Global Bio-chem Technology Group Company Limited Competitors by Total Assets
Key competitors of Global Bio-chem Technology Group Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
Global Bio-chem Technology Group Company Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Global Bio-chem Technology Group Company Limited generates 0.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Global Bio-chem Technology Group Company Limited generates $ 16.94 in net profit.
Global Bio-chem Technology Group Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.35 | 0.12 | 0.08 |
| Quick Ratio | 0.31 | 0.08 | 0.07 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-4.11 Billion | $ -5.84 Billion | $ -11.36 Billion |
Global Bio-chem Technology Group Company Limited - Advanced Valuation Insights
This section examines the relationship between Global Bio-chem Technology Group Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -12.8% |
| Total Assets | $4.54 Billion |
| Market Capitalization | $163.62 Million USD |
Valuation Analysis
Below Book Valuation: The market values Global Bio-chem Technology Group Company Limited's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Global Bio-chem Technology Group Company Limited's assets decreased by 12.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Global Bio-chem Technology Group Company Limited (2000–2024)
The table below shows the annual total assets of Global Bio-chem Technology Group Company Limited from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.54 Billion | -12.80% |
| 2023-12-31 | $5.21 Billion | -10.95% |
| 2022-12-31 | $5.85 Billion | -9.76% |
| 2021-12-31 | $6.48 Billion | -14.72% |
| 2020-12-31 | $7.60 Billion | -7.69% |
| 2019-12-31 | $8.23 Billion | -16.18% |
| 2018-12-31 | $9.82 Billion | -8.72% |
| 2017-12-31 | $10.76 Billion | +9.46% |
| 2016-12-31 | $9.83 Billion | -21.83% |
| 2015-12-31 | $12.58 Billion | -8.55% |
| 2014-12-31 | $13.76 Billion | -26.77% |
| 2013-12-31 | $18.78 Billion | -18.09% |
| 2012-12-31 | $22.93 Billion | -3.44% |
| 2011-12-31 | $23.75 Billion | +19.74% |
| 2010-12-31 | $19.84 Billion | +16.61% |
| 2009-12-31 | $17.01 Billion | +10.15% |
| 2008-12-31 | $15.44 Billion | +15.26% |
| 2007-12-31 | $13.40 Billion | +26.70% |
| 2006-12-31 | $10.57 Billion | +12.46% |
| 2005-12-31 | $9.40 Billion | +37.37% |
| 2004-12-31 | $6.84 Billion | +61.88% |
| 2003-12-31 | $4.23 Billion | +54.71% |
| 2002-12-31 | $2.73 Billion | +34.73% |
| 2001-12-31 | $2.03 Billion | +69.95% |
| 2000-12-31 | $1.19 Billion | -- |